Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01440881 · ClinicalTrials.gov registry record · Phase 2
Does Nesiritide Provide Renal Protection
A Phase 2 study, sponsored by University of Florida.
- Completed
- Registry status
- Phase 2
- Development phase
- 37
- Enrollment target
NCT01440881 is a Phase 2 study that has completed, run by University of Florida. The registered enrollment target is 37 participants.
The verdict
NCT01440881, a Phase 2 study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 37 participants
- Enrollment target
Study Summary
This project evaluates whether nesiritide, human recombinant brain natriuretic peptide, confers renal protection during cardiovascular surgery by attenuating the inflammatory response.
Interventions
- DRUG Placebo
- DRUG Nesiritide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2010-04 |
| Est. Completion | 2012-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01440881
The ClinicalTrials.gov registry entry for NCT01440881 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01440881 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01440881 about?
NCT01440881 is a clinical study titled "Does Nesiritide Provide Renal Protection". This project evaluates whether nesiritide, human recombinant brain natriuretic peptide, confers renal protection during cardiovascular surgery by attenuating the inflammatory response.
What is the current status of trial NCT01440881?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 37 participants. The study started on 2010-04. Estimated completion is 2012-12.
What interventions are being tested in trial NCT01440881?
The interventions under investigation include: Placebo (DRUG), Nesiritide (DRUG).
Who is sponsoring clinical trial NCT01440881?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.